טוען...
Measure for measure: minimal residual disease in CLL
In this issue of Blood, Kwok and colleagues have provided a wealth of retrospective clinical data that greatly expands our appreciation for the prognostic importance of flow-cytometric residual disease measurement across a spectrum of clinical presentations in chronic lymphocytic leukemia (CLL).(1)
שמור ב:
| הוצא לאור ב: | Blood |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5159707/ https://ncbi.nlm.nih.gov/pubmed/27979863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-11-745323 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|